DISCLOSEDQuarterly
Renaissance Technologies
Kalaris Therapeutics Inc · NASDAQ
66,151 sh · $381.7K
Filed 31 Mar 2026SEC 13Fview source
Renaissance Technologies
Kalaris Therapeutics Inc · NASDAQ
66,151 sh · $381.7K
Two Sigma Investments
Kalaris Therapeutics Inc · NASDAQ
30,650 sh · $176.8K